Oxford University Hospitals NHS Trust, Oxford, UK.
Curr Urol Rep. 2014 Jan;15(1):379. doi: 10.1007/s11934-013-0379-9.
The prevalence of chronic kidney disease continues to outpace the development of effective treatment strategies. For patients with advanced disease, renal replacement therapies approximate the filtration functions of the kidney at considerable cost and inconvenience, while failing to restore the resorptive and endocrine functions. Allogeneic transplantation remains the only restorative treatment, but donor shortage, surgical morbidity and the need for lifelong immunosuppression significantly limit clinical application. Emerging technologies in the fields of regenerative medicine and tissue engineering strive to address these limitations. We review recent advances in cell-based therapies, primordial allografts, bio-artificial organs and whole-organ bioengineering as they apply to renal regeneration. Collaborative efforts across these fields aim to produce a bioengineered kidney capable of restoring renal function in patients with end-stage disease.
慢性肾脏病的患病率持续超过有效治疗策略的发展。对于晚期疾病患者,肾脏替代疗法以相当大的成本和不便来模拟肾脏的过滤功能,同时未能恢复吸收和内分泌功能。同种异体移植仍然是唯一的恢复性治疗方法,但供体短缺、手术发病率以及对终身免疫抑制的需求显著限制了其临床应用。再生医学和组织工程领域的新兴技术努力解决这些限制。我们回顾了细胞治疗、原始同种异体移植物、生物人工器官和整个器官生物工程在肾脏再生中的最新进展。这些领域的合作努力旨在产生一种生物工程肾脏,能够恢复终末期疾病患者的肾功能。